Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconKYMRKymera Therapeutics$4.79bnn/an/a
us flag iconACADAcadia Pharmaceuticals$4.64bn50.23n/a
us flag iconSRRKScholar Rock Holding$4.59bnn/an/a
us flag iconAKROAkero Therapeutics$4.49bnn/an/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a
us flag iconALPNAlpine Immune Sciences$4.46bnn/an/a
us flag iconCRNXCrinetics Pharmaceuticals$4.43bnn/an/a
us flag iconVKTXViking Therapeutics$4.36bnn/an/a
us flag iconAPGEApogee Therapeutics$4.21bnn/an/a
us flag iconMRTXMirati Therapeutics$4.12bnn/an/a
us flag iconALKSVAlkermes$4.05bn18.02n/a
us flag iconACLXArcellx$4.02bnn/an/a
us flag iconCNTACentessa Pharmaceuticals$4.02bnn/an/a
us flag iconIMVTImmunovant$4.00bnn/an/a
us flag iconNAMSNewAmsterdam Pharma NV$4.00bnn/an/a
us flag iconGRALGrail$3.94bnn/an/a
us flag iconRYZBRayzebio$3.81bnn/an/a
us flag iconCBAYCymaBay Therapeutics$3.73bnn/an/a
us flag iconVCYTVeracyte$3.53bn84.74n/a
us flag iconIRONDisc Medicine$3.52bnn/an/a